Advanced search
Publication Cover
Hypertension in Pregnancy Volume 32, 2013 - Issue 2
Submit an article Journal homepage
496
Views
115
CrossRef citations to date
0
Altmetric
Research Article

Clinical characterization and outcomes of preeclampsia with normal angiogenic profile

Sarosh RanaDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MAUSACorrespondence[email protected]
,
William T. SchnettlerDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MAUSA
,
Camille PoweDepartment of Medicine, Brigham and Women’s Hospital, Harvard Medical School Boston, MAUSA
,
Julia WengerDivision of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School Boston, MAUSA
,
Saira SalahuddinDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MAUSA
,
Ana Sofia CerdeiraDivision of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MAUSA;Gulbenkian Programme for Advanced Medical Education LisbonPortugal
,
Stefan VerlohrenDepartment of Obstetrics, Campus Virchow-Clinic, Charité University Medicine BerlinGermany
,
Frank H. PerschelDepartment of Laboratory Medicine, Clinical Chemistry, and Pathobiochemistry, Charité University Medicine BerlinGermany
,
Zoltan AranyDivision of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MAUSA
,
Kee-Hak LimBoston Maternal Fetal Medicine Boston, MA
,
Ravi ThadhaniDivision of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School Boston, MAUSA
&
S. Ananth KarumanchiDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MAUSA;Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MAUSA;Howard Hughes Medical Institute Boston, MAUSA
 show all
Pages 189-201 | Published online: 31 May 2013

Citations (115)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (11)

Hooman Mirzakhani & Scott T. Weiss. (2022) Fetal sex and risk of preeclampsia: Dose maternal race matter?. The Journal of Maternal-Fetal & Neonatal Medicine 35:17, pages 3379-3387.
Read now
Ying Wang, Na Wu & Haitao Shen. (2021) A Review of Research Progress of Pregnancy with Twins with Preeclampsia. Risk Management and Healthcare Policy 14, pages 1999-2010.
Read now
Michael S. Tanner, Deborah De Guingand, Maya Reddy, Saskia Rowson, Daniel L. Rolnik, Fabricio Da Silva Costa, Mary-Ann Davey, Ben W. Mol, Euan M. Wallace & Kirsten R. Palmer. (2021) The effect of preexisting medical comorbidities on the preeclamptic phenotype: a retrospective cohort study. Hypertension in Pregnancy 40:4, pages 336-345.
Read now
Pia Härkin, Riitta Marttila, Tytti Pokka, Timo Saarela & Mikko Hallman. (2021) Survival analysis of a cohort of extremely preterm infants born in Finland during 2005–2013. The Journal of Maternal-Fetal & Neonatal Medicine 34:15, pages 2506-2512.
Read now
Louise Bjørkholt Andersen, Ralf Dechend, Jan Stener Jørgensen, Birgitte Møller Luef, Jan Nielsen, Torben Barington & Henrik Thybo Christesen. (2016) Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort. Hypertension in Pregnancy 35:3, pages 405-419.
Read now
Rafaela A. Costa, Mara S. Hoshida, Eliane A. Alves, Marcelo Zugaib & Rossana P. V. Francisco. (2016) Preeclampsia and superimposed preeclampsia: The same disease? The role of angiogenic biomarkers. Hypertension in Pregnancy 35:2, pages 139-149.
Read now
Kudret Erkenekli, Cantekin Iskender, Efser Oztas, Ayse Seval Özgü-Erdinç, Aykan Yucel & Dilek Uygur. (2015) Clinical, but Not Laboratory Features Are Predictive of Risk of Subsequent Development of Preeclampsia in Patients With Isolated Proteinuria After Midgestation. Hypertension in Pregnancy 34:4, pages 495-505.
Read now
Thushari I. Alahakoon, Weiyi Zhang, Brian J. Trudinger & Vincent W. Lee. (2014) Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles. The Journal of Maternal-Fetal & Neonatal Medicine 27:18, pages 1854-1859.
Read now
Sarosh Rana & S. Ananth Karumanchi. (2014) Response to Carbillon L et al. letter titled; “The imbalance of circulating angiogenic/anti-angiogenic factors is mild or absent in obese women destined to develop preeclampsia”. Hypertension in Pregnancy 33:4, pages 525-525.
Read now
Kedak Baltajian, Jonathan L. Hecht, Julia B. Wenger, Saira Salahuddin, Stefan Verlohren, Frank H. Perschel, Zsuzsanna K. Zsengeller, Ravi Thadhani, S. Ananth Karumanchi & Sarosh Rana. (2014) Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia. Hypertension in Pregnancy 33:4, pages 427-439.
Read now
Lionel Carbillon. (2014) The imbalance of circulating angiogenic/antiangiogenic factors is mild or absent in obese women destined to develop preeclampsia. Hypertension in Pregnancy 33:4, pages 524-524.
Read now

Articles from other publishers (104)

Tinnakorn Chaiworapongsa, Roberto Romero, Nardhy Gomez-Lopez, Manaphat Suksai, Dahiana M. Gallo, Eunjung Jung, Stanley M. Berry, Awoniyi Awonuga, Adi L. Tarca & David R. Bryant. (2023) Preeclampsia at term: evidence of disease heterogeneity based on the profile of circulating cytokines and angiogenic factors. American Journal of Obstetrics and Gynecology.
Crossref
Alexandros Velegrakis, Elisavet Kouvidi, Persefoni Fragkiadaki & Stavros Sifakis. (2023) Predictive value of the sFlt‑1/PlGF ratio in women with suspected preeclampsia: An update (Review). International Journal of Molecular Medicine 52:4.
Crossref
Thomas Rduch, Norbert Arn, Janis Kinkel, Tina Fischer, Isabelle Binet, René Hornung & Inge K. Herrmann. (2023) Magnetic blood purification‐based soluble fms‐like tyrosine kinase‐1 removal in comparison with dextran sulfate apheresis and therapeutic plasma exchange. Artificial Organs 47:8, pages 1309-1318.
Crossref
Tinnakorn Chaiworapongsa, Roberto Romero, Francesca Gotsch, Manaphat Suksai, Dahiana M. Gallo, Eunjung Jung, Arthur Krieger, Piya Chaemsaithong, Offer Erez & Adi L. Tarca. (2023) Preeclampsia at term can be classified into 2 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood. American Journal of Obstetrics and Gynecology 228:5, pages 569.e1-569.e24.
Crossref
Elżbieta Poniedziałek-Czajkowska, Radzisław Mierzyński & Bożena Leszczyńska-Gorzelak. (2023) Preeclampsia and Obesity—The Preventive Role of Exercise. International Journal of Environmental Research and Public Health 20:2, pages 1267.
Crossref
Dorota Sroka, Lisa-Antonia Lorenz-Meyer, Valerie Scherfeld, Julie Thoma, Andreas Busjahn, Wolfgang Henrich & Stefan Verlohren. (2023) Comparison of the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio Alone versus a Multi-Marker Regression Model for the Prediction of Preeclampsia-Related Adverse Outcomes after 34 Weeks of Gestation. Fetal Diagnosis and Therapy 50:3, pages 215-224.
Crossref
Max Hackelöer, Leon Schmidt & Stefan Verlohren. (2022) New advances in prediction and surveillance of preeclampsia: role of machine learning approaches and remote monitoring. Archives of Gynecology and Obstetrics 308:6, pages 1663-1677.
Crossref
Laura Ormesher, Suzanne Higson, Matthew Luckie, Stephen A. Roberts, Heather Glossop, Andrew Trafford, Elizabeth Cottrell, Edward D. Johnstone & Jenny E. Myers. (2022) Postnatal cardiovascular morbidity following preterm pre-eclampsia: An observational study. Pregnancy Hypertension 30, pages 68-81.
Crossref
Katarzyna Pankiewicz, Ewa Szczerba, Anna Fijałkowska, Janusz Sierdziński, Tadeusz Issat & Tomasz Mikołaj Maciejewski. (2022) The Impact of Coexisting Gestational Diabetes Mellitus on the Course of Preeclampsia. Journal of Clinical Medicine 11:21, pages 6390.
Crossref
Katrina Chau, Mikala Welsh, Angela Makris & Annemarie Hennessy. (2021) Progress in preeclampsia: the contribution of animal models. Journal of Human Hypertension 36:8, pages 705-710.
Crossref
Giorgina Barbara Piccoli, Massimo Torreggiani, Romain Crochette, Gianfranca Cabiddu, Bianca Masturzo, Rossella Attini & Elisabetta Versino. (2021) What a paediatric nephrologist should know about preeclampsia and why it matters. Pediatric Nephrology 37:8, pages 1733-1745.
Crossref
Leon J. Schmidt, Oliver Rieger, Mark Neznansky, Max Hackelöer, Lisa A. Dröge, Wolfgang Henrich, David Higgins & Stefan Verlohren. (2022) A machine-learning–based algorithm improves prediction of preeclampsia-associated adverse outcomes. American Journal of Obstetrics and Gynecology 227:1, pages 77.e1-77.e30.
Crossref
Carlos José Molina-Pérez, Ana Graciela Nolasco-Leaños, Reyes Ismael Carrillo-Juárez & Alfredo Leaños-Miranda. (2022) Clinical usefulness of angiogenic factors in women with chronic kidney disease and suspected superimposed preeclampsia. Journal of Nephrology 35:6, pages 1699-1708.
Crossref
Sarah Heimberger, Joana Lopes Perdigao, Ariel Mueller, Gabriel Arenas, Melissa Kuriloff, Colleen Duncan, Courtney Amegashie & Sarosh Rana. (2022) Women’s perspectives and attitudes towards the utility of angiogenic biomarkers in preeclampsia. Pregnancy Hypertension 28, pages 109-113.
Crossref
Chileshe M. Mabula‐Bwalya, Megan E. Smithmyer, Humphrey Mwape, Gabriel Chipili, Madelyn Conner, Bellington Vwalika, Kristina De Paris, Jeffrey S.A. Stringer & Joan T. Price. (2021) Association of mid‐trimester maternal angiogenic biomarkers with small‐for‐gestational‐age infants in an urban Zambian cohort: a nested case‐control study. International Journal of Gynecology & Obstetrics 157:3, pages 604-612.
Crossref
Anne Karge, Linus Desing, Bernhard Haller, Javier U. Ortiz, Silvia M. Lobmaier, Bettina Kuschel & Oliver Graupner. (2022) Performance of sFlt-1/PIGF Ratio for the Prediction of Perinatal Outcome in Obese Pre-Eclamptic Women. Journal of Clinical Medicine 11:11, pages 3023.
Crossref
Hao Yang, Fang Guo, Qin Guo, Yifei Wang, Ping He, Hongbo Zhang & Shuaiyu Wang. (2022) The clinical value of PlGF and the sFlt1/PlGF ratio in the management of hypertensive pregnancy disorders: A retrospective real-world study in China. Clinica Chimica Acta 528, pages 90-97.
Crossref
Offer Erez, Roberto Romero, Eunjung Jung, Piya Chaemsaithong, Mariachiara Bosco, Manaphat Suksai, Dahiana M. Gallo & Francesca Gotsch. (2022) Preeclampsia and eclampsia: the conceptual evolution of a syndrome. American Journal of Obstetrics and Gynecology 226:2, pages S786-S803.
Crossref
Eunjung Jung, Roberto Romero, Lami Yeo, Nardhy Gomez-Lopez, Piya Chaemsaithong, Adithep Jaovisidha, Francesca Gotsch & Offer Erez. (2022) The etiology of preeclampsia. American Journal of Obstetrics and Gynecology 226:2, pages S844-S866.
Crossref
Sarosh Rana, Suzanne D. Burke & S. Ananth Karumanchi. (2022) Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. American Journal of Obstetrics and Gynecology 226:2, pages S1019-S1034.
Crossref
Stefan Verlohren & Lisa-Antonia Dröge. (2022) The diagnostic value of angiogenic and antiangiogenic factors in differential diagnosis of preeclampsia. American Journal of Obstetrics and Gynecology 226:2, pages S1048-S1058.
Crossref
S. Ananth Karumanchi, Sarosh Rana & Robert N. Taylor. 2022. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy 165 185 .
Elżbieta Poniedziałek-Czajkowska & Radzisław Mierzyński. (2021) Could Vitamin D Be Effective in Prevention of Preeclampsia?. Nutrients 13:11, pages 3854.
Crossref
Katherine M. Johnson, Laura Smith, Anna M. Modest, Saira Salahuddin, S.A. Karumanchi, Sarosh Rana & Brett C. Young. (2021) Angiogenic factors and prediction for ischemic placental disease in future pregnancies. Pregnancy Hypertension 25, pages 12-17.
Crossref
Juilee S. Deshpande, Deepali P. Sundrani, Akriti S. Sahay, Sanjay A. Gupte & Sadhana R. Joshi. (2021) Unravelling the potential of angiogenic factors for the early prediction of preeclampsia. Hypertension Research 44:7, pages 756-769.
Crossref
Gabriel A. Arenas, Nga Y. Tang, Ariel Mueller, Joana Lopes Perdigao, Harjot Kaur, Jacques S. Abramowicz, Kathryn Mussatt, Kiang-Teck J. Yeo & Sarosh Rana. (2021) Use of the angiogenic biomarker profile to risk stratify patients with fetal growth restriction. American Journal of Obstetrics & Gynecology MFM 3:4, pages 100394.
Crossref
Elżbieta Poniedziałek-Czajkowska, Radzisław Mierzyński, Dominik Dłuski & Bożena Leszczyńska-Gorzelak. (2021) Prevention of Hypertensive Disorders of Pregnancy—Is There a Place for Metformin?. Journal of Clinical Medicine 10:13, pages 2805.
Crossref
Anne Karge, Alina Seiler, Sarah Flechsenhar, Bernhard Haller, Javier U. Ortiz, Silvia M. Lobmaier, Roland Axt-Fliedner, Christian Enzensberger, Kathrin Abel, Bettina Kuschel & Oliver Graupner. (2021) Prediction of adverse perinatal outcome and the mean time until delivery in twin pregnancies with suspected pre-eclampsia using sFlt-1/PIGF ratio. Pregnancy Hypertension 24, pages 37-43.
Crossref
Kristina B. Sole, Anne Cathrine Staff & Katariina Laine. (2021) Maternal diseases and risk of hypertensive disorders of pregnancy across gestational age groups. Pregnancy Hypertension.
Crossref
Marta Magatti, Alice Masserdotti, Anna Cargnoni, Andrea Papait, Francesca Romana Stefani, Antonietta Rosa Silini & Ornella Parolini. (2021) The Role of B Cells in PE Pathophysiology: A Potential Target for Perinatal Cell-Based Therapy?. International Journal of Molecular Sciences 22:7, pages 3405.
Crossref
Ana G. Nolasco-Leaños, Karla L. Ramírez-ValenzuelaReyes I. Carrillo-Juárez, Carlos J. Molina-Pérez, Irma Isordia-Salas & Alfredo Leaños-Miranda. (2021) Circulating angiogenic factors are associated with progression to preeclampsia and the occurrence of adverse outcomes in women with gestational hypertension. Journal of Hypertension 39:3, pages 573-580.
Crossref
Lisa Antonia Dröge, Frank Holger PerschelNatalia Stütz, Anna Gafron, Lisa FrankAndreas BusjahnWolfgang Henrich & Stefan Verlohren. (2021) Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine. Hypertension 77:2, pages 461-471.
Crossref
Jiawu Zhao, Rebecca P. Chow, Rebecca H. McLeese, Michelle B. Hookham, Timothy J. Lyons & Jeremy Y. Yu. (2020) Modelling preeclampsia: a comparative analysis of the common human trophoblast cell lines. FASEB BioAdvances 3:1, pages 23-35.
Crossref
U. Vivian Ukah, Beth A. Payne, Jennifer A. Hutcheon, Lucy C. Chappell, Paul T. Seed, Frances Inez Conti-Ramsden, J. Mark Ansermino, Laura A. Magee & Peter von Dadelszen. (2020) Placental growth factor for the prognosis of women with preeclampsia (fullPIERS model extension): context matters. BMC Pregnancy and Childbirth 20:1.
Crossref
Anne Karge, Lina Beckert, Philipp Moog, Bernhard Haller, Javier U. Ortiz, Silvia M. Lobmaier, Kathrin Abel, Sarah Flechsenhar, Bettina Kuschel & Oliver Graupner. (2020) Role of sFlt-1/PIGF ratio and uterine Doppler in pregnancies with chronic kidney disease suspected with Pre-eclampsia or HELLP syndrome. Pregnancy Hypertension 22, pages 160-166.
Crossref
Alfredo Leaños-MirandaAna Graciela Nolasco-LeañosReyes Ismael Carrillo-JuárezCarlos José Molina-PérezLiliana Janet Sillas-PardoLuis Manuel Jiménez-TrejoIrma Isordia-SalasKarla Leticia Ramírez-Valenzuela. (2020) Usefulness of the sFlt-1/PlGF (Soluble fms-Like Tyrosine Kinase-1/Placental Growth Factor) Ratio in Diagnosis or Misdiagnosis in Women With Clinical Diagnosis of Preeclampsia. Hypertension 76:3, pages 892-900.
Crossref
Anandita Umapathy, Lawrence W. Chamley & Joanna L. James. (2019) Reconciling the distinct roles of angiogenic/anti-angiogenic factors in the placenta and maternal circulation of normal and pathological pregnancies. Angiogenesis 23:2, pages 105-117.
Crossref
Helen PerryJulia BinderErkan KalafatStuart JonesBasky ThilaganathanAsma Khalil. (2020) Angiogenic Marker Prognostic Models in Pregnant Women With Hypertension. Hypertension 75:3, pages 755-761.
Crossref
Oliver Graupner, Anne Karge, Sarah Flechsenhar, Alina Seiler, Bernhard Haller, Javier U. Ortiz, Silvia M. Lobmaier, Roland Axt-Fliedner, Christian Enzensberger, Kathrin Abel & Bettina Kuschel. (2019) Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia. Archives of Gynecology and Obstetrics 301:2, pages 375-385.
Crossref
Catherine M. Bulka, Tracy A. Manuck & Rebecca C. Fry. 2020. Environmental Epigenetics in Toxicology and Public Health. Environmental Epigenetics in Toxicology and Public Health 109 123 .
Zineb Filali Khattabi, Marilisa Biolcati, Antioco Fois, Antoine Chatrenet, Delphine Laroche, Rossella Attini, Marie Therese Cheve & Giorgina Barbara Piccoli. (2019) Chronic kidney disease in preeclamptic patients: not found unless searched for—Is a nephrology evaluation useful after an episode of preeclampsia?. Journal of Nephrology 32:6, pages 977-987.
Crossref
Henri Boulanger, Guillaume Lefèvre, Salima Ahriz Saksi, Jedjiga Achiche, Sophie Bailleul, Dieudonné Ekoukou, Dominique Drouin, Corinne Sault, Nicolas Stawiarski & Emmanuel Dupuis. (2019) Intérêts potentiels des facteurs angiogéniques placentaires comme biomarqueurs dans la pré-éclampsie pour le clinicien. Néphrologie & Thérapeutique 15:6, pages 413-429.
Crossref
Ana Sofia Cerdeira, Joe O’Sullivan, Eric O. OhumaDeborah Harrington, Pawel Szafranski, Rebecca Black, Lucy Mackillop, Lawrence Impey, Catherine Greenwood, Tim James, Ian Smith, Aris T. PapageorghiouMarian Knight & Manu Vatish. (2019) Randomized Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia. Hypertension 74:4, pages 983-990.
Crossref
Takuji Tomimatsu, Kazuya Mimura, Shinya Matsuzaki, Masayuki Endo, Keiichi Kumasawa & Tadashi Kimura. (2019) Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors. International Journal of Molecular Sciences 20:17, pages 4246.
Crossref
Wei-zhen Lou, Fang Jiang, Jing Hu, Xiao-xu Chen, Ying-na Song, Xi-ya Zhou, Jun-tao Liu, Xu-ming Bian & Jin-song Gao. (2019) Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women. Disease Markers 2019, pages 1-7.
Crossref
Elizabeth A. Phipps, Ravi Thadhani, Thomas Benzing & S. Ananth Karumanchi. (2019) Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nature Reviews Nephrology 15:5, pages 275-289.
Crossref
Tiina Jääskeläinen, Seppo Heinonen, Esa Hämäläinen, Kari Pulkki, Jarkko Romppanen & Hannele Laivuori. (2018) Impact of obesity on angiogenic and inflammatory markers in the Finnish Genetics of Pre-eclampsia Consortium (FINNPEC) cohort. International Journal of Obesity 43:5, pages 1070-1081.
Crossref
Nnabuike Chibuoke Ngene, Jagidesa Moodley & Thajasvarie Naicker. (2019) The performance of pre-delivery serum concentrations of angiogenic factors in predicting postpartum antihypertensive drug therapy following abdominal delivery in severe preeclampsia and normotensive pregnancy. PLOS ONE 14:4, pages e0215807.
Crossref
M. Arigita. (2019) Diagnóstico, predicción y cribado de la preeclampsia. ¿Es el momento de cambiar la definición clásica de la preeclampsia?. Hipertensión y Riesgo Vascular 36:2, pages 59-62.
Crossref
Alfredo Leaños-Miranda, Inova Campos-Galicia, Karla Leticia Ramírez-Valenzuela, María Guadalupe Berumen-Lechuga, Irma Isordia-Salas & Carlos José Molina-Pérez. (2018) Urinary IgM excretion: a reliable marker for adverse pregnancy outcomes in women with chronic kidney disease. Journal of Nephrology 32:2, pages 241-251.
Crossref
Sarosh RanaElizabeth LemoineJoey P. GrangerS. Ananth Karumanchi. (2019) Preeclampsia. Circulation Research 124:7, pages 1094-1112.
Crossref
Ignacio Herraiz García, Elisa Llurba Olive, Alberto Galindo Izquierdo & Stefan Verlohren. (2019) Actualización del diagnóstico y el pronóstico de la preeclampsia en embarazos únicos con la ayuda del cociente sFlt-1/PlGF. Progresos de Obstetricia y Ginecología.
Crossref
Christine Contini, B. Sophia Winkler, Nicolai Maass, Ibrahim Alkatout, Karl Winkler & Ulrich Pecks. (2019) Concomitant intrauterine growth restriction alters the lipoprotein profile in preeclampsia. Pregnancy Hypertension 15, pages 154-160.
Crossref
AS Cerdeira, S Agrawal, AC Staff, CW Redman & M Vatish. (2018) Angiogenic factors: potential to change clinical practice in pre-eclampsia?. BJOG: An International Journal of Obstetrics & Gynaecology 125:11, pages 1389-1395.
Crossref
Langeza Saleh, Sarea I.M. Tahitu, A.H. Jan Danser, Anton H. van den Meiracker & Willy Visser. (2018) The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies. Pregnancy Hypertension 14, pages 222-227.
Crossref
Tiina Jääskeläinen, Seppo Heinonen, Esa Hämäläinen, Kari Pulkki, Jarkko Romppanen & Hannele Laivuori. (2018) Angiogenic profile in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort. Pregnancy Hypertension 14, pages 252-259.
Crossref
Amalie Bjerke Rieber-Mohn, Meryam Sugulle, Gerd Wallukat, Patji Alnæs-Katjavivi, Gro Leite Størvold, Nils Bolstad, Christopher WG Redman, Ralf Dechend & Anne Cathrine Staff. (2018) Auto-antibodies against the angiotensin II type I receptor in women with uteroplacental acute atherosis and preeclampsia at delivery and several years postpartum. Journal of Reproductive Immunology 128, pages 23-29.
Crossref
Zaher Armaly, Jimmy E. Jadaon, Adel Jabbour & Zaid A. Abassi. (2018) Preeclampsia: Novel Mechanisms and Potential Therapeutic Approaches. Frontiers in Physiology 9.
Crossref
Vardaman M. Buckalew. (2018) Role of endogenous digitalis-like factors in the clinical manifestations of severe preeclampsia: a systematic review. Clinical Science 132:12, pages 1215-1242.
Crossref
AbdAllah Khaled M. (2018) Body Mass Index Impact and Predictability on Preeclamptic Toxemia. Journal of Gynecological Research and Obstetrics, pages 009-014.
Crossref
Jessica Sheehan Tangren, Camille E. Powe, Jeffrey Ecker, Kate Bramham, Elizabeth Ankers, S. Ananth Karumanchi & Ravi Thadhani. (2018) Metabolic and Hypertensive Complications of Pregnancy in Women with Nephrolithiasis. Clinical Journal of the American Society of Nephrology 13:4, pages 612-619.
Crossref
C. Tardif, E. Dumontet, H. Caillon, E. Misbert, V. Dochez, D. Masson & N. Winer. (2018) Angiogenic factors sFlt-1 and PlGF in preeclampsia: Prediction of risk and prognosis in a high-risk obstetric population. Journal of Gynecology Obstetrics and Human Reproduction 47:1, pages 17-21.
Crossref
Holger Stepan & Janine Hoffmann. 2018. Preeclampsia. Preeclampsia 175 198 .
U. Vivian UkahJennifer A. HutcheonBeth PayneMatthew D. HaslamManu VatishJ. Mark AnserminoHelen BrownLaura A. MageePeter von Dadelszen. (2017) Placental Growth Factor as a Prognostic Tool in Women With Hypertensive Disorders of Pregnancy. Hypertension 70:6, pages 1228-1237.
Crossref
Langeza SalehYvonne VergouweAnton H. van den MeirackerKoen VerdonkHenk RusscherHenk A. BremerHans J. VersendaalEric A.P. SteegersA.H. Jan DanserWilly Visser. (2017) Angiogenic Markers Predict Pregnancy Complications and Prolongation in Preeclampsia. Hypertension 70:5, pages 1025-1033.
Crossref
Janine Hoffmann, Victoria Ossada, Marie Weber & Holger Stepan. (2017) An intermediate sFlt-1/PlGF ratio indicates an increased risk for adverse pregnancy outcome. Pregnancy Hypertension 10, pages 165-170.
Crossref
Belinda Jim & S. Ananth Karumanchi. (2017) Preeclampsia: Pathogenesis, Prevention, and Long-Term Complications. Seminars in Nephrology 37:4, pages 386-397.
Crossref
Giorgina Barbara Piccoli, Gianfranca Cabiddu, Santina Castellino, Giuseppe Gernone, Domenico Santoro, Gabriella Moroni, Donatella Spotti, Franca Giacchino, Rossella Attini, Monica Limardo, Stefania Maxia, Antioco Fois, Linda Gammaro & Tullia Todros. (2017) A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy. Journal of Nephrology 30:3, pages 307-317.
Crossref
Takuji Tomimatsu, Kazuya Mimura, Masayuki Endo, Keiichi Kumasawa & Tadashi Kimura. (2016) Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction. Hypertension Research 40:4, pages 305-310.
Crossref
Sarosh Rana & S. Ananth Karumanchi. 2017. Fetal and Neonatal Physiology. Fetal and Neonatal Physiology 1724 1732.e2 .
Pitchaphon Nissaisorakarn, Sairah Sharif & Belinda Jim. (2016) Hypertension in Pregnancy: Defining Blood Pressure Goals and the Value of Biomarkers for Preeclampsia. Current Cardiology Reports 18:12.
Crossref
Geoff K Frampton, Jeremy Jones, Micah Rose & Liz Payne. (2016) Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis. Health Technology Assessment 20:87, pages 1-160.
Crossref
Birgitte M. Luef, Louise B. Andersen, Kristina M. Renäult, Ellen A. Nohr, Jan S. Jørgensen & Henrik T. Christesen. (2016) Validation of hospital discharge diagnoses for hypertensive disorders of pregnancy. Acta Obstetricia et Gynecologica Scandinavica 95:11, pages 1288-1294.
Crossref
David E. Cantonwine, John D. Meeker, Kelly K. Ferguson, Bhramar Mukherjee, Russ Hauser & Thomas F. McElrath. (2016) Urinary Concentrations of Bisphenol A and Phthalate Metabolites Measured during Pregnancy and Risk of Preeclampsia. Environmental Health Perspectives 124:10, pages 1651-1655.
Crossref
Nathalie E. Marchand, Ganmaa Davaasambuu, Thomas F. McElrath, Enkhmaa Davaasambuu, Tsedmaa Baatar & Rebecca Troisi. (2016) Prevalence of pregnancy hypertensive disorders in Mongolia. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 6:4, pages 413-417.
Crossref
Kedak Baltajian, Surichhya Bajracharya, Saira Salahuddin, Anders H. Berg, Carl Geahchan, Julia B. Wenger, Ravi Thadhani, S. Ananth Karumanchi & Sarosh Rana. (2016) Sequential plasma angiogenic factors levels in women with suspected preeclampsia. American Journal of Obstetrics and Gynecology 215:1, pages 89.e1-89.e10.
Crossref
Elizabeth Phipps, Devika Prasanna, Wunnie Brima & Belinda Jim. (2016) Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines. Clinical Journal of the American Society of Nephrology 11:6, pages 1102-1113.
Crossref
Sajid ShahulDiego MedvedofskyJulia B. WengerJunaid NizamuddinSamuel M. BrownSurichhya BajracharyaSaira SalahuddinRavi ThadhaniAriel MuellerAvery TungRoberto M. LangZoltan AranyDaniel TalmorS. Ananth KarumanchiSarosh Rana. (2016) Circulating Antiangiogenic Factors and Myocardial Dysfunction in Hypertensive Disorders of Pregnancy. Hypertension 67:6, pages 1273-1280.
Crossref
S. Ananth Karumanchi. (2016) Angiogenic Factors in Preeclampsia. Hypertension 67:6, pages 1072-1079.
Crossref
Giorgina Barbara Piccoli, Gianfranca Cabiddu, Rossella Attini, Silvia Parisi, Federica Fassio, Valentina Loi, Martina Gerbino, Marilisa Biolcati, Antonello Pani & Tullia Todros. (2016) Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question). Current Hypertension Reports 18:5.
Crossref
Shi‐Bin Cheng, Akitoshi Nakashima & Surendra Sharma. (2015) Understanding Pre‐Eclampsia Using Alzheimer's Etiology: An Intriguing Viewpoint. American Journal of Reproductive Immunology 75:3, pages 372-381.
Crossref
M C Honigberg, D E Cantonwine, A M Thomas, K-H Lim, S I Parry & T F McElrath. (2015) Analysis of changes in maternal circulating angiogenic factors throughout pregnancy for the prediction of preeclampsia. Journal of Perinatology 36:3, pages 172-177.
Crossref
Sarah Rae Easter, David E. Cantonwine, Chloe A. Zera, Kee-Hak Lim, Samuel I. Parry & Thomas F. McElrath. (2016) Urinary tract infection during pregnancy, angiogenic factor profiles, and risk of preeclampsia. American Journal of Obstetrics and Gynecology 214:3, pages 387.e1-387.e7.
Crossref
Kristina Mattsson, Karin Källén, Anna Rignell-Hydbom, Stefan R. Hansson, Thomas F. McElrath, David E. Cantonwine & Lars Rylander. (2015) Maternal Smoking during Pregnancy and Daughters’ Preeclampsia Risk. PLOS ONE 10:12, pages e0144207.
Crossref
Mariana Widmer, Cristina Cuesta, Khalid S. Khan, Agustin Conde-Agudelo, Guillermo Carroli, Shalini Fusey, S. Ananth Karumanchi, Olav Lapaire, Pisake Lumbiganon, Evan Sequeira, Nelly Zavaleta, Tiziana Frusca, A. Metin Gülmezoglu & Marshall D. Lindheimer. (2015) Accuracy of angiogenic biomarkers at ⩽20weeks’ gestation in predicting the risk of pre-eclampsia: A WHO multicentre study. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 5:4, pages 330-338.
Crossref
Ignacio Herraiz, Elisa Simón, Paula Gómez-Arriaga, José Martínez-Moratalla, Antonio García-Burguillo, Elena Jiménez & Alberto Galindo. (2015) Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration. International Journal of Molecular Sciences 16:8, pages 19009-19026.
Crossref
Glenn E. Palomaki, James E. Haddow, Hamish R. M. Haddow, Saira Salahuddin, Carl Geahchan, Ana Sofia Cerdeira, Stefan Verlohren, Frank H. Perschel, Gary Horowitz, Ravi Thadhani, S. Ananth Karumanchi & Sarosh Rana. (2015) Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia. Prenatal Diagnosis 35:4, pages 386-393.
Crossref
Monica Sircar, Ravi Thadhani & S. Ananth Karumanchi. (2015) Pathogenesis of preeclampsia. Current Opinion in Nephrology and Hypertension 24:2, pages 131-138.
Crossref
Sundeep G. KeswaniSwathi BalajiAnna B. KatzAlice KingKhaled OmarMounira HabliCharles KlankeTimothy M. Crombleholme. (2015) Intraplacental Gene Therapy with Ad-IGF-1 Corrects Naturally Occurring Rabbit Model of Intrauterine Growth Restriction. Human Gene Therapy 26:3, pages 172-182.
Crossref
Louise Bjørkholt Andersen, Britta Frederiksen-Møller, Kathrine Work Havelund, Ralf Dechend, Jan Stener Jørgensen, Boye L. Jensen, Jan Nielsen, Sine Lykkedegn, Torben Barington & Henrik Thybo Christesen. (2015) Diagnosis of preeclampsia with soluble Fms–like tyrosine kinase 1/placental growth factor ratio: an inter–assay comparison. Journal of the American Society of Hypertension 9:2, pages 86-96.
Crossref
Elisa Llurba, Fatima Crispi & Stefan Verlohren. (2015) Update on the Pathophysiological Implications and Clinical Role of Angiogenic Factors in Pregnancy. Fetal Diagnosis and Therapy 37:2, pages 81-92.
Crossref
S. Ananth Karumanchi, Sarosh Rana & Robert N. Taylor. 2015. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy 113 132 .
Chris Gardiner & Manu Vatish. 2015. Disorders of Thrombosis and Hemostasis in Pregnancy. Disorders of Thrombosis and Hemostasis in Pregnancy 159 171 .
Tinnakorn Chaiworapongsa, Piya Chaemsaithong, Steven J. Korzeniewski, Lami Yeo & Roberto Romero. (2014) Pre-eclampsia part 2: prediction, prevention and management. Nature Reviews Nephrology 10:9, pages 531-540.
Crossref
Ignacio Herraiz, Lisa Antonia Dröge, Enery Gómez-Montes, Wolfgang Henrich, Alberto Galindo & Stefan Verlohren. (2014) Characterization of the Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio in Pregnancies Complicated by Fetal Growth Restriction. Obstetrics & Gynecology 124:2, pages 265-273.
Crossref
Maija Bry, Riikka Kivelä, Veli-Matti Leppänen & Kari Alitalo. (2014) Vascular Endothelial Growth Factor-B in Physiology and Disease. Physiological Reviews 94:3, pages 779-794.
Crossref
Eva Meler, Elena Scazzocchio, Anna Peguero, Stefania Triunfo, Eduard Gratacos & Francesc Figueras. (2014) Role of maternal plasma levels of placental growth factor for the prediction of maternal complications in preeclampsia according to the gestational age at onset. Prenatal Diagnosis 34:7, pages 706-710.
Crossref
Sarosh RanaS. Ananth KarumanchiMarshall D. Lindheimer. (2014) Angiogenic Factors in Diagnosis, Management, and Research in Preeclampsia. Hypertension 63:2, pages 198-202.
Crossref
JIMMY ESPINOZA. (2014) ANGIOGENIC IMBALANCES IN THE PATHOGENESIS OF PREGNANCY COMPLICATIONS. Fetal and Maternal Medicine Review 25:1, pages 42-58.
Crossref
Jean-Claude Forest, Sébastien Thériault, Jacques Massé, Emmanuel Bujold & Yves Giguère. (2014) Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women. Clinical Chemistry and Laboratory Medicine (CCLM) 52:8.
Crossref
Atsuo Hidaka & Osamu Nakamoto. (2014) Retraction: Etiopathology of preeclampsia — Recent progress from the perspective of a poor/ischemic placenta. Hypertension Research in Pregnancy 2:2, pages 98-107.
Crossref
William Mifsud & Neil J. Sebire. (2014) Placental Pathology in Early-Onset and Late-Onset Fetal Growth Restriction. Fetal Diagnosis and Therapy 36:2, pages 117-128.
Crossref
Dionne Tannetta & Ian Sargent. (2013) Placental Disease and the Maternal Syndrome of Preeclampsia: Missing Links?. Current Hypertension Reports 15:6, pages 590-599.
Crossref
Arvind Goel & Sarosh Rana. (2013) Angiogenic factors in preeclampsia. Current Opinion in Nephrology & Hypertension 22:6, pages 643-650.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.